Account
Inquiry
Direct-Vision-Peptides Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide (LY-3437943) is a novel triple receptor agonist that simultaneously targets GIP, GLP-1, and GCG receptors, offering a comprehensive approach to metabolic regulation research. This peptide demonstrates particular potency at the GIP receptor, making it valuable for studying appetite control and energy metabolism pathways.
The compound's multi-receptor activation profile enables researchers to investigate several key metabolic processes:
• GIP receptor activation influences central appetite regulation, potentially reducing food intake through direct effects on brain satiety centers
• GLP-1 receptor engagement supports research into glycemic control mechanisms and gastric motility
• GCG receptor stimulation facilitates studies of energy expenditure, fat oxidation, and adipose tissue remodeling
Retatrutide's unique ability to promote 'beiging' of white adipose tissue makes it particularly interesting for thermogenesis and metabolic rate research. The compound's triple-action mechanism provides a valuable tool for investigating potential approaches to metabolic disorders.
For research use only. Not for human consumption.
